🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Paul A. Hamlin

Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-9500-1804

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma”.

Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma

Haematologica(2020)10.3324/haematol.2019.243246

N/A

2.9DataRank · unranked

58 citations

Stephanie Lobaugh, Martina Pennisi, Hei Ton Chan, Yakup Batlevi, Josel D. Ruiz +20 more

Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma

European Journal of Cancer(2020)10.1016/j.ejca.2019.12.006

N/A

1.3DataRank · unranked

29 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2183

N/A

0.850DataRank · unranked

22 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Blood Cancer Journal(2020)10.1038/s41408-020-00340-z

N/A

0.798DataRank · unranked

204 citations

Fushen Sha, Anna Alperovich, Ai Ni, Katy Smith, Zhitao Ying +20 more

TP53mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

Blood Advances(2023)10.1182/bloodadvances.2023009953

N/A

0.505DataRank · unranked

28 citations

Nivetha Ganesan, Zachary D. Epstein‐Peterson, Alison J. Moskowitz, Robert Stuver, Catherine Maccaro +27 more

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010003

N/A

0.470DataRank · unranked

22 citations

Soo‐Jeong Kim, Samantha Brown, Theresa A. Elko, Josel D. Ruiz, Danielle M Hanley +19 more

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

Blood Cancer Journal(2022)10.1038/s41408-022-00620-w

N/A

0.291DataRank · unranked

5 citations

Michelle Okwali, Anna Alperovich, Philip Caron, Lorenzo Falchi, Audrey Hamilton +22 more

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Blood Cancer Journal(2024)10.1038/s41408-024-01148-x

N/A

0.208DataRank · unranked

3 citations

Efrat Luttwak, Alfredo Rivas‐Delgado, Helen Irawan, Alexander P. Boardman, Philip Caron +26 more

Mutational and copy number analysis at diagnosis and relapse of mantle cell lymphoma

Haematologica(2025)10.3324/haematol.2024.286813

N/A

0.104DataRank · unranked

1 citations

Manik Uppal, Serena Zheng, Kurt S. Bantilan, Connie Lee Batlevi, Zachary D. Epstein‐Peterson +21 more

Retrospective characterization of nodal marginal zone lymphoma

Blood Advances(2023)10.1182/bloodadvances.2022009587

N/A

0DataRank · unranked

8 citations

Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip Caron +24 more

Data from Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring

(2023)10.1158/1078-0432.c.6530889.v1

N/A

0DataRank · unranked

0 citations

Laure Michaud, Karissa Whiting, Reiko Nakajima, Chelsea Nichols, Stephanie De Frank +19 more

CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas

Blood Neoplasia(2024)10.1016/j.bneo.2024.100031

N/A

0DataRank · unranked

1 citations

Kurt S. Bantilan, Erel Joffe, M. Lia Palomba, Ariela Noy, Philip Caron +12 more

Long‐term outcomes of patients with limited‐stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era

British Journal of Haematology(2022)10.1111/bjh.18590

N/A

0DataRank · unranked

2 citations

Brandon S. Imber, Michelle Okwali, Paul A. Hamlin, Anita Kumar, Oscar Lahoud +11 more

120 | DETECTION OF INTRATUMORAL MICROORGANISMS AND THEIR IMPACT ON OUTCOMES IN UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA

Hematological Oncology(2025)10.1002/hon.70093_120

N/A

0DataRank · unranked

0 citations

Chad Vanderbilt, Teng Fei, Ticiane Henriques Santa Rita, A. Rivas Delgado, Annie Qiu +31 more

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

Blood Advances(2021)10.1182/bloodadvances.2021004939

N/A

0DataRank · unranked

42 citations

Karen Chau, Jasme Lee, Jisun Lee, Dana L. Casey, Joanna C. Yang +13 more

Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer—Preliminary data

Journal of the American Geriatrics Society(2023)10.1111/jgs.18267

N/A

0DataRank · unranked

17 citations

Paul A. Hamlin, William P. Tew, Kelly M. Trevino, Amy L. Tin, Armin Shahrokni +6 more